Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com


Summary of Product Characteristics last updated on the eMC: 04/04/2011
SPC Diprobase Cream


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Diprobase Cream


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

No pharmacologically active components.


Go to top of the page
3. PHARMACEUTICAL FORM

Cream


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Diprobase Cream is an emollient, moisturising and protective cream for the follow-up treatment with topical steroids or in spacing such treatment. It may also be used as diluent for topical steroids. Diprobase Cream is recommended for the symptomatic treatment of red inflamed, damaged, dry or chapped skin, the protection of raw skin areas and as a pre-bathing emollient for dry/eczematous skin to alleviate drying areas.


Go to top of the page
4.2 Posology and method of administration

Adults and Children:

The cream should be applied to the dry skin areas as often as is required and rubbed well into the skin.


Go to top of the page
4.3 Contraindications

There are no absolute contraindications to the use of the cream other than hypersensitivity to any of the ingredients.


Go to top of the page
4.4 Special warnings and precautions for use

None stated.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None stated.


Go to top of the page
4.6 Pregnancy and lactation

None stated.


Go to top of the page
4.7 Effects on ability to drive and use machines

None stated.


Go to top of the page
4.8 Undesirable effects

Skin reactions including pruritus, rash, erythema, skin exfoliation, burning sensation, hypersensitivity, pain, dry skin and bullous dermatitis have been reported with product use.


Go to top of the page
4.9 Overdose

None stated.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Diprobase Cream contains no active ingredients and has no pharmacological action. The ingredients provide emollient, moisturising action on dry or chapped skin.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable due to topical administration and direct action on the skin.


Go to top of the page
5.3 Preclinical safety data

There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SmPC.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Chlorocresol

Macrogol Cetostearyl Ether (Cetomacrogol)

Cetostearyl alcohol

Liquid paraffin

White soft paraffin

Phosphoric acid

Sodium dihydrogen phosphate

Sodium hydroxide

Purified water


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

15, 50 and 100gm aluminium tubes - 60 months

500gm pump presentations – 36 months


Go to top of the page
6.4 Special precautions for storage

Store below 25°C.


Go to top of the page
6.5 Nature and contents of container

50, 100 and 15gm aluminium epoxy lined membrane tubes with plastic caps.

500gm polypropylene piston pack with polyethylene cap and daplen pump, disc and tube or PVC cap, polypropylene pump, polyolefin disc and HDPE tube or

500gm polypropylene jar (container) with a polypropylene dispenser head and cover, the pump system consists of a polyethylene follower plate, a polypropylene pump cylinder, a polyethylene piston with a glass and a polypropylene valve.


Go to top of the page
6.6 Special precautions for disposal and other handling

Not applicable.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Merck Sharp & Dohme Limited

Hertford Road

Hoddesdon

Hertfordshire

EN11 9BU, UK


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00025/0575


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

12 April 1996 / 12 April 2001


Go to top of the page
10. DATE OF REVISION OF THE TEXT

21 March 2011


Go to top of the page
11 LEGAL CATEGORY

GSL

© Merck Sharp & Dohme Limited 2011. All rights reserved.

DipCrm/UK/03-11/7



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/1857/SPC/


Active Ingredients/Generics

 
   no active ingredients